Cephalalgia

Editorial Commentary
pp. 765-768(1)

Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies
pp. 769-778(10)
Authors: Dahlöf C.

Acupuncture for recurrent headaches: a systematic review of randomized controlled trials
pp. 779-786(8)
Authors: Melchart D.; Linde K.; Fischer P.; White A.; Allais G.; Vickers A.; Berman B.

Headache in intracranial tumors
pp. 787-790(4)
Authors: Pfund Z.; Szapáry L.; Jászberényi O.; Nagy F.; Czopf J.

Headache in Ehlers–Danlos syndrome
pp. 791-796(6)
Author: Jacome D.

Migraine-related seizures in an epileptic population
pp. 797-801(5)
Authors: Veliogglu S.; Özmenoglu M.

Intracellular Mg⁺⁺ concentration and electromyographical ischemic test in juvenile headache
pp. 802-809(8)
Authors: Mazzotta G.; Sarchielli P.; Alberti A.; Gallai V.

Nitric oxide pathway, Ca²⁺, and serotonin content in platelets from patients suffering from chronic daily headache
pp. 810-816(7)
Authors: Sarchielli P.; Alberti A.; Russo S.; Codini M.; Panico R.; Floridi A.; Gallai V.

Interobserver reliability of diagnostic criteria for cervicogenic headache
pp. 817-823(7)
Authors: van Suijlekom J.; de Vet H.; van den Berg S.; Weber W.

Possible predictive factors in the prognosis of migraine with aura
pp. 824-830(7)
Authors: Cologno D.; Torelli P.; Manzoni C.

Migraine consultation patterns in primary care. Results from the PCAOM study 1994–96
pp. 831-840(10)
Authors: Krobot K.; Schröder-Bernhardi D.; Pfaffenrath V.

Loss of topographic memory and prosopagnosia during migraine aura
pp. 841-843(3)
Authors: Martins I.; Cunha e Sá M.

Announcements
pp. 844-844(1)